New Delhi, June 8: The cumulative number of COVID-19 vaccine doses administered in the country has reached close to 23.88 Cr (23,88,40,635) as per the 7 pm provisional report today.
13,32,471 beneficiaries of the age group 18-44 years received their first dose and 76,723 beneficiaries of the same age group received their second dose of COVID vaccine today. Cumulatively, 3,17,37,869 personsacross 37 States/UTs have received their first dose and total 3,16,134 have received their second dose since the start of Phase-3 of the vaccination drive. Bihar, Delhi, Gujarat, Haryana, Karnataka, Madhya Pradesh, Maharashtra, Rajasthan, Tamil Nadu, Uttar Pradesh and West Bengal have administered more than 10 lakh beneficiaries of the age group 18-44 years for the first dose of COVID vaccine.
The table below shows the cumulative vaccine doses administered to 18-44 years age group till now.
|S.No.||State||1st Dose||2nd Dose|
|1||A & N Islands||11,989||0|
|8||Dadra & Nagar Haveli||52,681||0|
|9||Daman & Diu||64,156||0|
|15||Jammu & Kashmir||2,87,959||20,422|
The total of 23,88,40,635 include 99,95,552 Healthcare Workers (HCWs) who have taken the 1st dose and 68,91,662 HCWs who have taken the 2nd dose, 1,63,80,521 Frontline Workers (FLWs) (1st dose), 87,26,071 FLWs (2nd dose), 3,17,37,869 for 18-44 years of age group (1st dose) and 3,16,134 for 18-44 years of age group (2nd dose). 7,25,46,765 for over 45 years old to 60 years old (1st Dose), 1,15,34,478 for over 45 years old to 60 years old (2nd dose), 6,12,75,505 for above 60 years (1st Dose) and 1,94,36,078 for above 60 years (2nd Dose).
As on Day-144 of the vaccination drive (8th June, 2021), total of 25,58,652 vaccine doses were given. 22,67,842 beneficiaries were vaccinated for 1st dose and 2,90,810 beneficiaries received 2nd dose of vaccine as per the provisional report till 7 P.M. Final reports would be completed for the day by late tonight.
The vaccination exercise as a tool to protect the most vulnerable population groups in the country from COVID-19 continues to be regularly reviewed and monitored at the highest level.